https://orcid.org/0000-0002-5257-8678
Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Xu Li, Huifan Ji, Dezhi Zhang, Meishan Jin, Xiaolin Guo & Pujun Gao. (2022) Lymphoepithelioma‑Like Cholangiocarcinoma with Hepatitis C Virus Infection Treated by Microwave Ablation: A Literature Review and Case Report. Cancer Management and Research 14, pages 2155-2160.
Read now
Read now
Alessandro Rizzo, Antonio Cusmai, Angela Dalia Ricci, Giovanni Brandi & Gennaro Palmiotti. (2022) Combination systemic therapies with immune checkpoint inhibitors in biliary tract cancer: effective but not enough?. Expert Review of Gastroenterology & Hepatology 16:4, pages 307-310.
Read now
Read now
Alessandro Rizzo, Antonio Cusmai & Gennaro Palmiotti. (2022) Second-line fluoropyrimidine-based doublet chemotherapy for advanced biliary tract cancer: a new standard of care?. Expert Review of Gastroenterology & Hepatology 16:3, pages 201-203.
Read now
Read now
MacKenzie L Owen & Eliza W Beal. (2021) Minimally Invasive Surgery for Intrahepatic Cholangiocarcinoma: Patient Selection and Special Considerations. Hepatic Medicine: Evidence and Research 13, pages 137-143.
Read now
Read now
Alessandro Rizzo, Angela Dalia Ricci & Giovanni Brandi. (2021) Ivosidenib in IDH-mutant cholangiocarcinoma: where do we stand?. Expert Review of Precision Medicine and Drug Development 6:3, pages 217-224.
Read now
Read now
Alessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, Alessandro Di Federico & Giovanni Brandi. (2021) FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issue. Expert Review of Gastroenterology & Hepatology 15:5, pages 567-574.
Read now
Read now
Satoshi Nara, Minoru Esaki, Daisuke Ban, Takeshi Takamoto, Takahiro Mizui & Kazuaki Shimada. (2021) Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer. Expert Review of Gastroenterology & Hepatology 15:5, pages 537-545.
Read now
Read now
Alessandro Rizzo, Angela Dalia Ricci & Giovanni Brandi. (2021) Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer. Expert Opinion on Investigational Drugs 30:4, pages 343-350.
Read now
Read now
Articles from other publishers (39)
Arianeb Mehrabi, Mohammad Golriz, Ali Ramouz, Elias Khajeh, Ahmed Hammad, Thilo Hackert, Beat Müller-Stich, Oliver Strobel, Sadeq Ali-Hasan-Al-Saegh, Omid Ghamarnejad, Mohammed Al-Saeedi, Christoph Springfeld, Christian Rupp, Philipp Mayer, Markus Mieth, Benjamin Goeppert, Katrin Hoffmann & Markus W. Büchler. (2023) Promising Outcomes of Modified ALPPS for Staged Hepatectomy in Cholangiocarcinoma. Cancers 15:23, pages 5613.
Crossref
Crossref
Munenobu Kashiwa & Ryo Matsushita. (2023) Model-based cost-utility analysis of gemcitabine, cisplatin, and S-1 as triple therapy for advanced biliary tract cancer. International Journal of Clinical Pharmacy 45:4, pages 875-883.
Crossref
Crossref
Wattana Leowattana, Tawithep Leowattana & Pathomthep Leowattana. (2023) Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer. World Journal of Gastrointestinal Oncology 15:6, pages 959-972.
Crossref
Crossref
Tian-mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-jie Tao, Xi-yun Chen, Qin Han, Zhuo Cheng, Pei-pei Shang, Yu-long Dong, He-ming Xu, Lie-ping Guo, Dong-sheng Chen, Yun-jie Song, Chuang Qi, Wang-long Deng & Zhen-gang Yuan. (2023) Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer. Nature Communications 14:1.
Crossref
Crossref
Mohammad Arham Siddiq, Amna Qamber, Muhammad Saqlain Mustafa, Hussain Sohail Rangwala & Muhammad Usama Siddiq. (2023) Durvalumab and biliary tract cancer: a breakthrough in the field of oncology. International Journal of Surgery: Global Health 6:1, pages e109-e109.
Crossref
Crossref
Jiaqiang Deng, Huani Wang, Yutong Liang, Lili Zhao, Yan Li, Yan Yan, Hong Zhao, Xiao Zhang & Fangdong Zou. (2023) miR-15a-5p enhances the malignant phenotypes of colorectal cancer cells through the STAT3/TWIST1 and PTEN/AKT signaling pathways by targeting SIRT4. Cellular Signalling 101, pages 110517.
Crossref
Crossref
Zhen-Gang Yuan, Tian-Mei Zeng & Chen-Jie Tao. (2022) Current and emerging immunotherapeutic approaches for biliary tract cancers. Hepatobiliary & Pancreatic Diseases International 21:5, pages 440-449.
Crossref
Crossref
Chaiwat Aphivatanasiri, Prakasit Sa-Ngiamwibool, Sakkarn Sangkhamanon, Piyapharom Intarawichian, Waritta Kunprom, Malinee Thanee, Piya Prajumwongs, Narong Khuntikeo, Attapol Titapun, Apiwat Jareanrat, Vasin Thanasukarn, Tharatip Srisuk, Vor Luvira, Kulyada Eurboonyanun, Julaluck Promsorn, Watcharin Loilome, Aileen Wee & Supinda Koonmee. (2022) Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. Frontiers in Medicine 9.
Crossref
Crossref
Ruijia Chen, Yalan Zhang, Kongying Lin, Defu Huang, MaoJin You, Yanjin Lai, Jinye Wang, Yingying Hu & Na Li. (2022) Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers. Frontiers in Pharmacology 13.
Crossref
Crossref
Alessandro Rizzo, Riccardo Carloni, Giorgio Frega, Andrea Palloni, Alessandro Di Federico, Angela Dalia Ricci, Raffaele De Luca, Simona Tavolari & Giovanni Brandi. (2022) Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical Center. Current Oncology 29:7, pages 5084-5090.
Crossref
Crossref
Supinda Koonmee, Sakkarn Sangkhamanon, Piyapharom Intarawichian, Chaiwat Aphivatanasiri, Waritta Kunprom, Prakasit Sa-ngiamwibool, Suwit Balthaisong, Chitsakul Phuyao, Piya Prajumwongs, Reza Alaghehbandan & Malinee Thanee. (2022) The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand. Frontiers in Public Health 10.
Crossref
Crossref
Li-Hong Xing, Li-Yong Zhuo, Jia-Ning Wang, Yan Zhang, Feng-Ying Zhu, Chu Wang, Xiao-Ping Yin & Bu-Lang Gao. (2022) Values of MRI Imaging Presentations in the Hepatobiliary Phase, DWI and T2WI Sequences in Predicting Pathological Grades of Intrahepatic Mass-Forming Cholangiocarcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Zhiqing Duan, Yinuo Zhang, Yajie Tang, Ruqing Gao, Jing Bao & Bo Liang. (2022) Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: A systematic review. Translational Oncology 20, pages 101414.
Crossref
Crossref
Li-Hong Xing, Li-Yong Zhuo, Yu Zhang, Xi Ma, Ze-Peng Ma, Ying-Jia Zhao, Xiao-Ping Yin & Bu-Lang Gao. (2022) DWI Combined With Hepatobiliary-Phase Enhanced Imaging Can Better Differentiate Cholangiocarcinoma From Atypical Liver Abscesses. Frontiers in Oncology 12.
Crossref
Crossref
Anantapat Seeherunwong, Naesinee Chaiear, Narong Khuntikeo & Chatchai Ekpanyaskul. (2022) The Proportion of Occupationally Related Cholangiocarcinoma: A Tertiary Hospital Study in Northeastern Thailand. Cancers 14:10, pages 2386.
Crossref
Crossref
Ye Chen, Baoxia Zhang, Chang Liu, Ye Cao, Cheng Lyu & Meng Qiu. (2022) Clinical efficacy of adjuvant treatments for patients with resected biliary tract cancer: a systematic review and network meta-analysis. BMJ Open 12:4, pages e051421.
Crossref
Crossref
Chun-Yi Tsai, Shang-Yu Wang, Kun-Ming Chan, Wei-Chen Lee, Tse-Ching Chen, Ta-Sen Yeh, Yi-Yin Jan & Chun-Nan Yeh. (2022) Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients. Journal of Personalized Medicine 12:4, pages 540.
Crossref
Crossref
Sandra Kang, Bassel F. El-Rayes & Mehmet Akce. (2022) Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers. Cancers 14:7, pages 1748.
Crossref
Crossref
Edoardo Troncone, Fabio Gadaleta, Omero Alessandro Paoluzi, Cristina Maria Gesuale, Vincenzo Formica, Cristina Morelli, Mario Roselli, Luca Savino, Giampiero Palmieri, Giovanni Monteleone & Giovanna Del Vecchio Blanco. (2022) Endoscopic Ultrasound Plus Endoscopic Retrograde Cholangiopancreatography Based Tissue Sampling for Diagnosis of Proximal and Distal Biliary Stenosis Due to Cholangiocarcinoma: Results from a Retrospective Single-Center Study. Cancers 14:7, pages 1730.
Crossref
Crossref
Francesco Enrico D’Amico, Claudia Mescoli, Silvia Caregari, Alessio Pasquale, Ilaria Billato, Remo Alessandris, Jacopo Lanari, Domenico Bassi, Riccardo Boetto, Francesco D’Amico, Alessandro Vitale, Sara Lonardi, Enrico Gringeri & Umberto Cillo. (2022) Impact of Positive Radial Margin on Recurrence and Survival in Perihilar Cholangiocarcinoma. Cancers 14:7, pages 1680.
Crossref
Crossref
Tadahisa Inoue, Itaru Naitoh, Rena Kitano, Mayu Ibusuki, Yuji Kobayashi, Yoshio Sumida, Yukiomi Nakade, Kiyoaki Ito & Masashi Yoneda. (2022) Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma. Current Oncology 29:4, pages 2240-2251.
Crossref
Crossref
Hirotaka Suto, Yumiko Inui & Atsuo Okamura. (2022) Predicting Chemotherapy-Related Adverse Events in Elderly Cancer Patients with Prior Anticancer Therapy. Current Oncology 29:4, pages 2185-2192.
Crossref
Crossref
Qian Li, Yi Wei, Feng Che, Tong Zhang, Shan Yao, Jian Zhao, YuHui Zhang, Hehan Tang & Bin Song. (2022) Multiparametric Magnetic Resonance Imaging Improves the Prognostic Outcomes in Patients With Intrahepatic Cholangiocarcinoma After Curative-Intent Resection. Frontiers in Oncology 12.
Crossref
Crossref
Xiaolei Zhou. (2022) Meta-analysis of the diagnostic performance of serum carbohydrate antigen 19-9 for the detection of gallbladder cancer. The International Journal of Biological Markers 37:1, pages 81-89.
Crossref
Crossref
Felix Thol, Simon Johannes Gairing, Carolin Czauderna, Thomas Thomaidis, Thomas Gamstätter, Yvonne Huber, Johanna Vollmar, Johanna Lorenz, Maurice Michel, Fabian Bartsch, Lukas Müller, Roman Kloeckner, Peter Robert Galle, Marcus-Alexander Wörns, Jens Uwe Marquardt, Markus Moehler, Arndt Weinmann & Friedrich Foerster. (2022) Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer. JHEP Reports 4:3, pages 100417.
Crossref
Crossref
Yao Jin, Jiayan Wei, Yiming Weng, Jia Feng, Zexi Xu, Peiwei Wang, Xue Cui, Xinyi Chen, Jinsong Wang & Min Peng. (2022) Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-Analysis. Frontiers in Oncology 12.
Crossref
Crossref
Lauren F. Huang, Augustine Hong, Gino Cioffi, Asrar Alahmadi, Tin-Yun Tang, Lee M. Ocuin, Nirav Patil, David L. Bajor, Joel N. Saltzman, Amr Mohamed, Eva Selfridge, Monica Webb Hooper, Jill Barnholtz-Sloan & Richard T. Lee. (2022) Associations of Racial and Ethnic Category, Age, Comorbidities, and Socioeconomic Factors on Concordance to NCCN Guidelines for Patients With High-Risk Biliary Tract Cancers After Surgery. Frontiers in Oncology 12.
Crossref
Crossref
Alessandro Rizzo, Angela Dalia Ricci, Antonio Cusmai, Silvana Acquafredda, Giuseppe De Palma, Giovanni Brandi & Gennaro Palmiotti. (2022) Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future. Current Oncology 29:2, pages 551-564.
Crossref
Crossref
Katsunori Sekine, Ichiro Yasuda, Shinpei Doi, Noriyuki Kuniyoshi, Takayuki Tsujikawa, Yuichi Takano, Masatoshi Mabuchi, Kosuke Takahashi, Masashi Kawamoto, Mikiko Takahashi, Tatsuya Aso, Tatsuhiko Miyazaki & Takuji Iwashita. (2022) Peroral Cholangioscopy-Guided Targeted Biopsy versus Conventional Endoscopic Transpapillary Forceps Biopsy for Biliary Stricture with Suspected Bile Duct Cancer. Journal of Clinical Medicine 11:2, pages 289.
Crossref
Crossref
Florian Nima Fleckenstein, Maximilian Julius Roesel, Maja Krajewska, Timo Alexander Auer, Federico Collettini, Tazio Maleitzke, Georg Böning, Giovanni Federico Torsello, Uli Fehrenbach & Bernhard Gebauer. (2021) Combining Transarterial Radioembolization (TARE) and CT-Guided High-Dose-Rate Interstitial Brachytherapy (CT-HDRBT): A Retrospective Analysis of Advanced Primary and Secondary Liver Tumor Treatment. Cancers 14:1, pages 72.
Crossref
Crossref
Ya Jun Liu, Alphonse Houssou Hounye, Zheng Wang, Xiaowei Liu, Jun Yi & Min Qi. (2021) Identification and Validation of Three Autophagy-Related Long Noncoding RNAs as Prognostic Signature in Cholangiocarcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Hanjie Hu, Gang Xu, Shunda Du, Zhiwen Luo, Hong Zhao & Jianqiang Cai. (2021) The role of lymph node dissection in intrahepatic cholangiocarcinoma: a multicenter retrospective study. BMC Surgery 21:1.
Crossref
Crossref
Angela Dalia Ricci & Alessandro Rizzo. (2021) Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?. Medicina 57:12, pages 1301.
Crossref
Crossref
Matthias P. Fabritius, Najib Ben Khaled, Wolfgang G. Kunz, Jens Ricke & Max Seidensticker. (2021) Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma—Role of Interventional Radiology. Journal of Clinical Medicine 10:23, pages 5574.
Crossref
Crossref
Zahra Mojtahedi, Ji Won Yoo, Karen Callahan, Neeraj Bhandari, Donghui Lou, Katayoon Ghodsi & Jay J. Shen. (2021) Inpatient Palliative Care Is Less Utilized in Rare, Fatal Extrahepatic Cholangiocarcinoma: A Ten-Year National Perspective. International Journal of Environmental Research and Public Health 18:19, pages 10004.
Crossref
Crossref
Alessandro Rizzo. (2021) Targeted Therapies in Advanced Cholangiocarcinoma: A Focus on FGFR Inhibitors. Medicina 57:5, pages 458.
Crossref
Crossref
Tim Reese, Gregor Pagel, Bettina A. Bause, York von Rittberg, Kim C. Wagner & Karl J. Oldhafer. (2021) Complex Liver Resections for Intrahepatic Cholangiocarcinoma. Journal of Clinical Medicine 10:8, pages 1672.
Crossref
Crossref
Jyotsna Singh, Durgesh Shukla, Sanjiv Gupta, Braj Raj Shrivastav & Pramod Kumar Tiwari. (2021) Clinical epidemiology of gallbladder cancer in North-Central India and association of immunological markers, NLR, MLR and PLR in the diagnostic/prognostic prediction of GBC. Cancer Treatment and Research Communications 28, pages 100431.
Crossref
Crossref
Alessandro Rizzo. (2021) The evolving landscape of systemic treatment for advanced hepatocellular carcinoma and biliary tract cancer. Cancer Treatment and Research Communications 27, pages 100360.
Crossref
Crossref